Diabetes Shouldn’t Define You

    Not Recruiting
Updated on 21 April 2022


Diabetes Shouldn’t Define You


Diabetes impacts the lives of millions of people each year, but it shouldn’t define who you are. If you’ve been diagnosed with type 2 diabetes and are overweight you may already know how important it is to monitor your blood sugar, eat healthy and be active.

Physicians in your area are studying an investigational medication compared to an already approved medication in the treatment of type 2 diabetes.

Eligible participants are overweight and have type 2 diabetes. To qualify you must also be taking Metformin for the treatment of diabetes for at least 3 months. Patients receiving treatment with other diabetes medications within the past 3 months will not be allowed.

If you qualify, you will receive all study-related care, including physical exams, lab services, and study medications. During participation you will remain on a dose of Metformin.

For more information please call,
Diablo Clinical Research at 925-930-7267

Condition Weight Loss
Clinical Study IdentifierTX134499
Last Modified on21 April 2022

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note